If you would like to explore the possibility of participating in a clinical trial at Guthrie, please call 1-800-836-0388.

As a Guthrie cancer patient you will have the unique opportunity to participate in one or more of some 100 clinical research trials that involve new treatments for many cancer types.

As a Guthrie patient you may have the unique opportunity to take part in clinical research trials for atrial fibrillation, congestive heart failure, 脂质紊乱, heart attack and many more cardiology disease states.

As a Guthrie patient you may have an opportunity to take part in clinical research trials for celiac disease, 克罗恩氏病, 溃疡性结肠炎, 返流性疾病, hepatitis and many more gastroenterology disease states.

Clinical trials study new ways to prevent, detect and treat disease. If you take part in research, you help advance new investigational medical therapies. 

标题: A descriptive and comparative analysis of frailty in rural versus urban cancer patients undergoing major surgical oncologic procedures
部门: 肿瘤学
诊断: 肿瘤学-概论
Sub-Investigator (s):
赞助商: 内部
Details (Indentifier #): NCT05694338
标题: A Phase 2, Dose-finding, Randomized,
双盲, Placebo-controlled, Multicenter
Study to Evaluate the Safety and Efficacy of
Efavaleukin Alfa Induction Therapy in Subjects
with Moderately to Severely Active Ulcerative
结肠炎
部门: 胃肠病学
诊断: Gastrointestinal - Ulcerative 结肠炎
首席研究员: 马修·林肯
Sub-Investigator (s):
赞助商: 安进公司
Details (Indentifier #): 04987307
标题: A第三期, 多中心, 随机, 双盲, Chronic-dosing, 与这些相应平行的组织, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of MEDI3506 in Participants with Symptomatic Chronic Obstructive 肺 Disease (COPD) with a 历史 of COPD Exacerbations (OBERON)
部门: 肺
诊断: 肺-慢性阻塞性肺病
首席研究员: Boyd Taylor Hehn，医学博士
赞助商: 阿斯特拉捷利康
Details (Indentifier #): 05166889
标题: 一个随机, 非盲, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice in 病人 With Triple Negative 乳房 Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy
部门: 肿瘤学
诊断: 乳房
首席研究员: Joyson Poulose, MD
Sub-Investigator (s):
赞助商: 吉利德科学公司
Details (Indentifier #): NCT05633654
标题: A011801: The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive 乳房 Cancer): COMPASSHER2 Residual Disease (RD), 一个双盲, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib
部门: 肿瘤学
诊断: 乳房——辅助
首席研究员: Joyson Poulose, MD
Sub-Investigator (s):
赞助商: 联盟
Details (Indentifier #): NCT04457596
标题: A021806, A PHASE III TRIAL OF PERIOPERATIVE VERSUS ADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREATIC CANCER
部门: 肿瘤学
诊断: 肿瘤学-概论
首席研究员: Joyson Poulose, MD
Sub-Investigator (s):
赞助商: NCI
Details (Indentifier #): NCT04340141
标题: A031704: PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib With Nivolumab: A第三期 Trial in Metastatic Untreated Renal Cell Cancer [PDIGREE]
部门: 肿瘤学
诊断: 生殖-泌尿-肾脏
首席研究员: Joyson Poulose, MD
Sub-Investigator (s):
赞助商: 联盟
Details (Indentifier #): NCT03793166
标题: A151216 ALCHEMIST, Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial
部门: 肿瘤学
诊断: 肺-杂项
首席研究员: Joyson Poulose, MD
Sub-Investigator (s):
赞助商: 联盟
Details (Indentifier #): NCT02194738
标题: A221805: Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in 病人 With Stage II-III Colorectal Cancer
部门: 肿瘤学
诊断: Gastrointestinal - Colon-Rectal
首席研究员: Joyson Poulose, MD
Sub-Investigator (s):
赞助商: 联盟
Details (Indentifier #): NCT04137107
标题: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles as Early Goal Directed Therapy for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS):
部门: 肺
诊断: 传染性疾病
首席研究员: James J Walsh, MD, MSHA, FACP, FCCP
赞助商: 直接的生物制剂
Details (Indentifier #): NCT05354141
显示 1-10 of 40 结果